Product Overview
[Drug name]
Generic name: Terbinafine hydrochloride vaginal effervescent tablets
Trade name: Fulankang Terbinafine hydrochloride vaginal effervescent tablets 50mg*7 tablets
Pinyin full code: ZuoLanKang YanSuanTeBiZuoFenYinDaoPaoTengPian 50mg*7Pian
[Main ingredients]
The main ingredient of this product is: Terbinafine hydrochloride, its chemical name is: (E)-N-(6,6-dimethyl-2-heptene-4-ynyl)-N-methyl-1-naphthylamine·hydrochloride. Molecular formula: C21H25N·HCl Molecular weight: 327.89
[Properties]
This product is white or off-white tablets.
[Indications/Main functions]
Vulvovaginal candidiasis.
[Precautions]
1. If abnormal liver function, allergic reaction, local vaginal pain, etc. occur, the drug should be discontinued in time. 2. Use with caution in patients with liver and kidney dysfunction. Consult a doctor before use.
[Drug Interactions]
Those who are allergic to terbinafine or any of the ingredients in the preparation are prohibited from using this product. Those with severe liver and kidney dysfunction should not use this product.
[Specifications]
50mg*7 tablets
[Usage and Dosage]
Take out one tablet before going to bed every night and insert it into the posterior fornix of the vagina. Use the medicine continuously for 1 week as a course of treatment.
[Adverse Reactions]
The adverse reactions of this product include local irritation and allergic reactions, which manifest as irritation, vaginal itching, redness and swelling, etc. Literature reports that the adverse reactions of other dosage forms of terbinafine (such as tablets, creams, etc.) include: 1. Gastrointestinal reactions. 2. Occasionally, aminotransferase elevation or granulocytopenia is seen, which can generally be restored after stopping the drug. In very rare cases, hepatobiliary dysfunction occurs. The U.S. Food and Drug Administration (FDA) issued a message in May 2000, clarifying that terbinafine is hepatotoxic. 3. Topical use may cause local mild burning sensation, itching and other irritation symptoms or local skin dryness, sometimes accompanied by joint pain and myalgia. 4. There are reports that mild skin reactions (such as urticaria and other rashes) may occur after medication, and very few patients have severe skin reactions (such as Stevens-Johnson syndrome and toxic epidermal necrolysis). 5. There are also reports that very few patients have increased red blood cells in the urine after medication. 6. Rare taste changes.
[Contraindications]
It is contraindicated for those who are allergic to terbinafine or any ingredient in the preparation. It is contraindicated for those with severe liver and kidney dysfunction.
